Berlin, the state enters the biotech group CureVac with a share of 300 million

2020-06-15T12:10:54.984Z

The firm is conducting research for Coronavirus vaccineShare June 15, 2020 The German federal government joins the biotechnology company CureVac with a contribution of € 300 million for the Covid-19 vaccine race. This was announced by the Minister of Economy, Peter Altmaier. "The Federal Development Bank Kfw will acquire approximately 23% of the shares for € 300 million," explained the minister, according to Die Welt. The aim is to guarantee the fi...